Salipro Biotech presents at PEGS Europe Virtual

Join us at PEGS Europe Virtual on November 9-12! Our CEO, Jens Frauenfeld, will be discussing drug development against challenging targets including GPCRs and Ion Channels using the Salipro® Technology platform on November 12 at 4pm CET.

Event link

Previous
Previous

Salipro Biotech presents at Antibody Engineering & Therapeutics Virtual

Next
Next

Salipro Biotech and DyNAbind enter collaboration agreement